Poland· PL-100409068

Caramlo

A candesartan und amlodipin product containing candesartanum cilexetili + amlodipinum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 6 of our 19 countries.

ATC C09DB07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCaramloATCC09DB07REGISTER NO.PL-100409068PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Candesartan und amlodipin is registered in 6 of 19 countries.

Countries holding a registration under ATC C09DB07 (candesartan und amlodipin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Candesartan und amlodipin · ATC C09DB07

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Candesartanum cilexetili + Amlodipinum
Manufacturer
Zentiva, k.s.
Country
Poland (PL)
ATC code
C09DB07
ATC class
Candesartan und Amlodipin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

1 priced
  • gtin
    05909991418076
    28 szt.
    PLN 23.34
  • gtin
    05909991418090
  • gtin
    05909991418106
  • gtin
    05909991418113
  • gtin
    05909991418120
  • gtin
    05909991418069
  • gtin
    05909991418083

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for candesartan und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan und amlodipin · interactions on record

8 records

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f58d1aee-a030-430a-bf06-7bab9b590f8a
GET /v1/drugs/f58d1aee-a030-430a-bf06-7bab9b590f8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "16 mg + 5 mg",
  "packaging": "05909991418069 ¦ Rp ¦ 134502\n14 tabl.\n05909991418076 ¦ Rp ¦ 134503\n28 tabl.\n05909991418083 ¦ Rp ¦ 134504\n30 tabl.\n05909991418090 ¦ Rp ¦ 134505\n56 tabl.\n05909991418106 ¦ Rp ¦ 134506\n84 tabl.\n05909991418113 ¦ Rp ¦ 134507\n90 tabl.\n05909991418120 ¦ Rp ¦ 134508\n98 tabl.",
  "substance": "Candesartanum cilexetili 16 mg + Amlodipinum 5 mg",
  "common_name": "Candesartanum cilexetili + Amlodipinum",
  "pl_product_id": "100409068",
  "pozwolenie_nr": "25620",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about candesartan und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.